FLT3-ITD occurs particularly in AML with normal cytogenetics, where it occurs in up to 40% cases, and those with rare t(6;9) translocation involving DEK/CAN gene fusion, where it occurs in up to 70%–80% [8]. Here, FLT3 is linked to acute myeloid leukemia.